Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pravastatin, a 3-hydroxy-3-methyl-glutharyl coenzyme A inhibitor does not show pleiotropic effects in patients with systemic lupus erythematosus.

× No keyword cloud information.

4 in total

Review 1. Prevention of cardiovascular disease in systemic lupus erythematosus--proposed guidelines for risk factor management.

Authors: J Wajed; Y Ahmad; P N Durrington; I N Bruce
Journal: Rheumatology (Oxford) Date: 2003-07-16 Impact factor: 7.580

2. Tumor necrosis factor-alpha as a potential target in the treatment of systemic lupus erythematosus: a role for the HMG-CoA reductase inhibitor simvastatin.

Authors: Przemyslaw J Kotyla; Bogna Sliwinska-Kotyla; Eugene J Kucharz
Journal: J Rheumatol Date: 2006-11 Impact factor: 4.666

3. A pravastatin dose-escalation study in systemic lupus erythematosus.

Authors: Karen H Costenbader; Matthew H Liang; Lori B Chibnik; Juliet Aizer; Hannah Kwon; Victoria Gall; Elizabeth W Karlson
Journal: Rheumatol Int Date: 2007-04-03 Impact factor: 2.631

4. Atorvastatin therapy improves endothelial-dependent vasodilation in patients with systemic lupus erythematosus: an 8 weeks controlled trial.

Authors: G A Ferreira; T P Navarro; R W Telles; L E C Andrade; E I Sato
Journal: Rheumatology (Oxford) Date: 2007-08-10 Impact factor: 7.580

4 in total

3 in total

1. The role of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors (statins) in modern rheumatology.

Authors: Przemyslaw Kotyla
Journal: Ther Adv Musculoskelet Dis Date: 2010-10 Impact factor: 5.346

2. Treatment with apolipoprotein A-1 mimetic peptide reduces lupus-like manifestations in a murine lupus model of accelerated atherosclerosis.

Authors: Jennifer M P Woo; Zhuofeng Lin; Mohamad Navab; Casey Van Dyck; Yvette Trejo-Lopez; Krystal M T Woo; Hongyun Li; Lawrence W Castellani; Xuping Wang; Noriko Iikuni; Ornella J Rullo; Hui Wu; Antonio La Cava; Alan M Fogelman; Aldons J Lusis; Betty P Tsao
Journal: Arthritis Res Ther Date: 2010-05-18 Impact factor: 5.156

3. Short course of simvastatin has no effect on markers of endothelial activation in normolipidemic patients with systemic sclerosis.

Authors: Przemyslaw J Kotyla
Journal: J Int Med Res Date: 2018-03-20 Impact factor: 1.671

3 in total